-+ 0.00%
-+ 0.00%
-+ 0.00%

Sunshine Lake Pharma sets board meeting to review interim results, consider dividend

PUBT·08/19/2026 08:35:00
Listen to the news
Sunshine Lake Pharma sets board meeting to review interim results, consider dividend
  • Guangdong HEC Pharmaceutical will hold a board meeting on Aug. 31, 2026 to review interim results for H1 2026.
  • Directors will also consider an interim dividend at the meeting.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guangdong HEC Pharmaceutical Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260819-12289931), on August 19, 2026, and is solely responsible for the information contained therein.